In contrast, renal architecture appeared normal in kidneys from all treatment groups harvested at 18 weeks (not shown) and there was no evidence of renal AA amyloidosis in kidneys from SAA-treated mice in the older groups of mice (Supplementary Figure 2). The gene discussed is SAA2; the disease is AA amyloidosis.